A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

by Coppola, D., Liu, Y.N., Gopal, S., Remmerie, B., Samtani, M.N., Hough, D.W., Nuamah, I., Sulaiman, A., Pandina, G.
Published 2012